For comments, suggestions
Created with Raphaël 2.1.0 15.11.2010 Formal examination (assignment of filing date) 08.12.2010 Preliminary and substantive examination 30.09.2011 Publication of the decision of grant (B1) 31.03.2012 Completion of the opposition filing period 30.04.2012 Issuance of patent (C1) 15.11.2015 Valid until 30.06.2017 Publication of the decision of forfeiture, the term of re-establishment has expired

Patent lapsed


(11)Number of the document4126
(21)Number of the applicationa 2010 0129
(22)Filing date of the application2010.11.15
 Date of filing the request for examination (de fond) 15.11.2010
(71)Name(s) of applicant(s), code of the countryINSTITUTIA PUBLICA UNIVERSITATEA DE STAT DIN MOLDOVA, MD;
(72)Name(s) of inventor(s), code of the countryGULEA Aurelian, MD; JALBĂ Angela, MD; BARBĂ Nicanor, MD; ŢAPCOV Victor, MD; SOFRONI Larisa, MD; POIRIER Donald, CA;
(73)Name(s) of owner(s), code of the countryUNIVERSITATEA DE STAT DIN MOLDOVA, MD;
(54)Title of the inventionN,N'-[4,4'-(perfluoro-1,4-phenylenedioxy)-bis(4,1-phenylene)]-bis[2-(pyridine-2-ilmethylene)hydrazinecarbothioamide] and use thereof as  prostate cancer LNCaP cell proliferation inhibitor  
(13)Kind-of-document code
C1, BOPI 04/2012
B1, BOPI 09/2011
(51)International Patent Classification C07C 337/08 (2006.01); C07C 25/13 (2006.01); C07C 25/24 (2006.01); C07D 213/48 (2006.01); A61K 31/175 (2006.01); A61K 31/03 (2006.01); A61P 35/00 (2006.01); A61P 35/04 (2006.01); A61P 13/08 (2006.01);
(19)CountryMD
(45)Date of publication of patent granting decision:2011.09.30
(47)Date of issuance of patent2012.04.30
 Substantive examiner(s)LEVIŢCHI Svetlana, JOVMIR Tudor
 Payment for maintenance up to the date2015.11.15
 Date of patent termination2015.11.15
 Date of publication of the termination of patent, with the right of restoration2016.06.30
 Date of publication of the termination of patent, without the right of restoration2017.06.30
Up
/inventions/Details.aspx?id=a+2010+0129